新生児スクリーニングの世界市場予測2018-2026

Inkwood Researchが発行した調査報告書(INKW803031)
◆英語タイトル:GLOBAL NEWBORN SCREENING MARKET FORECAST 2018-2026
◆商品コード:INKW803031
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2108年2月19日
◆ページ数:170
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD4,500 ⇒換算¥508,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。

Inkwood Researchが調査・発行した本調査レポートでは、新生児スクリーニングの世界市場について調査・分析し、新生児スクリーニングの世界市場動向、市場予測、セグメント別分析、主要地域別分析(アメリカ市場、ヨーロッパ市場、アジア市場)、新生児スクリーニングの世界市場規模、関連企業分析などを含め、以下の構成でお届けいたします。
【レポートの概要】

KEY FINDINGSGrowth in the global newborn screening market is expected to be driven by factors like rising prevalence of newborn diseases and technological advancements in newborn screening. By the end of the forecast years of 2018-2026, the market is predicted to exhibit a CAGR of 13.58%.
MARKET INSIGHTS
The global newborn screening market is segmented on the basis of test type, technology and products. The test type segments include dry blood spot test, hearing screen test, and critical congenital heart disease (CCHD) test. The market by technology includes electrophoresis, hearing screen technology, tandem mass spectrometry, DNA based assays, pulse oximetry technology, and enzymes & immunoassay. The product segment of the market includes new-born screening reagents & assay kits and new-born screening instruments.
REGIONAL INSIGHTS
Regional segmentation of the market is done into North America, Asia-Pacific, Europe and rest of world. APAC market is expected to showcase the fastest growth over the forecast period. However, the North American market continues to dominate in terms of the total revenue generated. U.S and Canada are the significant markets in this region. Compensatory rules & regulations of newborn screening market in the United States are majorly contributing to the market’s progress.
COMPETITIVE INSIGHTS
Companies like Ab Sciex Llc (U.S.) (Acquired by Danaher), Bio-Rad Laboratories Inc, Biotek Instruments Inc., Cardinal Health Inc, Agilent Technology Inc, GE Healthcare, Natus Medical Incorporated, Masimo Corporation, Medtronic Plc, Neogen Labs Pvt. Ltd, Thermo Fisher Scientific Inc, Perkinelmer Inc, Waters Corporation, Zen Tech Sa, and Trivitron Healthcare are engaged in this market.

【レポートの目次】

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. NORTH AMERICA HOLDS MAJOR SHARE OF THE GLOBAL NEWBORN SCREENING MARKET
3.2.2. NEWBORN SCREENING INSTRUMENTS DOMINATE THE PRODUCTS SEGMENT
3.2.3. DRY BLOOD SPOT TEST DOMINATES THE TEST TYPE SEGMENT
3.2.4. DECREASING MORTALITY RATE
4. MARKET DYNAMICS
4.1. MARKET DEFINITION
4.2. DRIVERS
4.2.1. INCREASING PREVALENCE OF NEWBORN DISEASES
4.2.2. GROWING INCIDENCE OF FETAL HEALTH-RELATED ABNORMALITIES
4.2.3. GOVERNMENT SUPPORT TOWARDS NEWBORN CHILD HEALTH
4.2.4. RISING AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE
4.2.5. TECHNOLOGICAL ADVANCEMENTS IN NEWBORN SCREENING
4.2.6. INCREASE IN NUMBER OF PREGNANT WOMEN WITH ADVANCED MATERNAL AGE
4.3. RESTRAINTS
4.3.1. LACK OF PROPER HEALTHCARE INFRASTRUCTURE FOR NEWBORN BABIES IN DEVELOPING COUNTRIES
4.3.2. SOCIO-ECONOMIC BARRIERS IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING
4.4. OPPORTUNITY
4.4.1. INCREASING FERTILITY RATES ACROSS THE GLOBE
4.4.2. UNTAPPED OPPORTUNITY IN DEVELOPING COUNTRIES
4.5. CHALLENGES
4.5.1. LACK OF SKILLED PROFESSIONAL
5. MARKET BY PRODUCT TYPE
5.1. NEWBORN SCREENING INSTRUMENTS
5.1.1. HEARING SCREENING INSTRUMENTS
5.1.2. NEWBORN DISORDER SCREENING INSTRUMENTS
5.1.3. PULSE OXIMETRY
5.2. NEWBORN SCREENING REAGENTS & ASSAY KITS
6. MARKET BY TEST TYPE
6.1. HEARING SCREENING TEST
6.2. CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST
6.3. DRY BLOOD SPOT TEST
7. MARKET BY TECHNOLOGY
7.1. HEARING SCREEN TECHNOLOGY
7.2. ELECTROPHORESIS
7.3. TANDEM MASS SPECTROMETRY
7.4. PULSE OXIMETRY TECHNOLOGY
7.5. DNA BASED ASSAYS
7.6. ENZYMES & IMMUNOASSAYS
8. KEY ANALYTICS
8.1. PORTER’S 5 FORCE ANALYSIS
8.1.1. THREATS OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE PRODUCTS
8.1.3. BARGAINING POWER OF BUYERS
8.1.4. BARGAINING POWER OF SUPPLIERS
8.1.5. INTENSITY OF COMPETITIVE RIVALRY
8.2. KEY BUYING CRITERIA
8.2.1. RELIABILITY
8.2.2. COST
8.2.3. AVAILABILITY
8.2.4. TECHNOLOGICAL ADVANCEMENT
8.3. VALUE CHAIN ANALYSIS
8.3.1. RAW MATERIAL SUPPLIERS
8.3.2. MANUFACTURERS
8.3.3. DISTRIBUTORS
8.3.4. END-USERS
8.4. REGULATORY FRAMEWORK
8.5. INVESTMENT OUTLOOK
8.5.1. REGIONAL OUTLOOK
8.5.2. INVESTMENT OUTLOOK
9. GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1. UNITED STATES
9.1.2. CANADA
9.2. EUROPE
9.2.1. UNITED KINGDOM (U.K)
9.2.2. FRANCE
9.2.3. GERMANY
9.2.4. NORDICS
9.2.5. RUSSIA
9.2.6. REST OF EUROPE
9.3. ASIA-PACIFIC
9.3.1. CHINA
9.3.2. INDIA
9.3.3. JAPAN
9.3.4. AUSTRALIA
9.3.5. REST OF ASIA-PACIFIC
9.4. ROW
9.4.1. LATIN AMERICA
9.4.2. MIDDLE EAST & AFRICA
10. COMPETITIVE LANDSCAPE
10.1. MARKET SHARE ANALYSIS
10.1.1. PERKINELMER, INC.
10.1.2. BIO-RAD LABORATORIES
10.1.3. TRIVITRON HEALTHCARE
10.1.4. AGILENT TECHNOLOGIES INC.
10.2. TOP WINNING STRATEGIES
10.3. COMPANY PROFILES
10.3.1. AB SCIEX LLC (U.S.) (ACQUIRED BY DANAHER)
10.3.1.1. OVERVIEW
10.3.1.2. PRODUCT PORTFOLIO
10.3.1.3. STRATEGIC INITIATIVES
10.3.1.4. SCOT ANALYSIS
10.3.1.5. STRATEGIC ANALYSIS
10.3.2. BIOTEK INSTRUMENTS INC.
10.3.2.1. OVERVIEW
10.3.2.2. PRODUCT PORTFOLIO
10.3.2.3. SCOT ANALYSIS
10.3.2.4. STRATEGIC ANALYSIS
10.3.3. BIO-RAD LABORATORIES INC.
10.3.3.1. OVERVIEW
10.3.3.2. PRODUCT PORTFOLIO
10.3.3.3. STRATEGIC INITIATIVES
10.3.3.4. SCOT ANALYSIS
10.3.3.5. STRATEGIC ANALYSIS
10.3.4. CARDINAL HEALTH INC.
10.3.4.1. OVERVIEW
10.3.4.2. PRODUCT PORTFOLIO
10.3.4.3. SCOT ANALYSIS
10.3.4.4. STRATEGIC ANALYSIS
10.3.5. GE HEALTHCARE
10.3.5.1. OVERVIEW
10.3.5.2. PRODUCT PORTFOLIO
10.3.5.3. SCOT ANALYSIS
10.3.5.4. STRATEGIC ANALYSIS
10.3.6. AGILENT TECHNOLOGY INC
10.3.6.1. OVERVIEW
10.3.6.2. PRODUCT PORTFOLIO
10.3.6.3. STRATEGIC INITIATIVES
10.3.6.4. SCOT ANALYSIS
10.3.6.5. STRATEGIC ANALYSIS
10.3.7. MASIMO CORPORATION
10.3.7.1. OVERVIEW
10.3.7.2. PRODUCT PORTFOLIO
10.3.7.3. STRATEGIC INITIATIVES
10.3.7.4. SCOT ANALYSIS
10.3.7.5. STRATEGIC ANALYSIS
10.3.8. NATUS MEDICAL INCORPORATED
10.3.8.1. OVERVIEW
10.3.8.2. PRODUCT PORTFOLIO
10.3.8.3. STRATEGIC INITIATIVES
10.3.8.4. SCOT ANALYSIS
10.3.8.5. STRATEGIC ANALYSIS
10.3.9. MEDTRONIC PLC
10.3.9.1. OVERVIEW
10.3.9.2. PRODUCT PORTFOLIO
10.3.9.3. SCOT ANALYSIS
10.3.9.4. STRATEGIC ANALYSIS
10.3.10. THERMO FISHER SCIENTIFIC INC.
10.3.10.1. OVERVIEW
10.3.10.2. PRODUCT PORTFOLIO
10.3.10.3. SCOT ANALYSIS
10.3.10.4. STRATEGIC ANALYSIS
10.3.11. NEOGEN LABS PVT. LTD.
10.3.11.1. OVERVIEW
10.3.11.2. PRODUCT PORTFOLIO
10.3.11.3. STRATEGIC INITIATIVES
10.3.11.4. SCOT ANALYSIS
10.3.11.5. STRATEGIC ANALYSIS
10.3.12. PERKINELMER INC.
10.3.12.1. OVERVIEW
10.3.12.2. PRODUCT PORTFOLIO
10.3.12.3. STRATEGIC INITIATIVES
10.3.12.4. SCOT ANALYSIS
10.3.12.5. STRATEGIC ANALYSIS
10.3.13. ZEN TECH SA
10.3.13.1. OVERVIEW
10.3.13.2. PRODUCT PORTFOLIO
10.3.13.3. SCOT ANALYSIS
10.3.13.4. STRATEGIC ANALYSIS
10.3.14. WATERS CORPORATION
10.3.14.1. OVERVIEW
10.3.14.2. PRODUCT PORTFOLIO
10.3.14.3. STRATEGIC INITIATIVES
10.3.14.4. SCOT ANALYSIS
10.3.14.5. STRATEGIC ANALYSIS
10.3.15. TRIVITRON HEALTHCARE
10.3.15.1. OVERVIEW
10.3.15.2. PRODUCT PORTFOLIO
10.3.15.3. STRATEGIC INITIATIVES
10.3.15.4. SCOT ANALYSIS
10.3.15.5. STRATEGIC ANALYSIS

LIST OF TABLES
TABLE 1 GLOBAL NEWBORN SCREENING MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 2 GLOBAL INCIDENCE OF CHROMOSOMAL ABNORMALITIES IN NEWBORNS
TABLE 3 10 LEADING CAUSE OF INFANT DEATH IN THE UNITED STATES IN 2015
TABLE 4 GLOBAL NEWBORN SCREENING MARKET BY PRODUCT 2018-2026 ($ MILLION)
TABLE 5 GLOBAL NEWBORN SCREENING INSTRUMENTS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 6 GLOBAL NEWBORN SCREENING INSTRUMENTS MARKET SUB SEGMENTS 2018-2026 ($ MILLION)
TABLE 7 GLOBAL NEWBORN SCREENING REAGENTS & ASSAY KITS MARKET BY GEOGRAPHY 2018-2026 ($MILLION)
TABLE 8 GLOBAL NEWBORN SCREENING MARKET BY TEST TYPE 2018-2026 ($ MILLION)
TABLE 9 GLOBAL HEARING SCREENING TEST MARKET BY GEOGRAPHY 2018-2026 ($MILLION)
TABLE 10 GLOBAL CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST BY GEOGRAPHY 2018-2026 ($MILLION)
TABLE 11 GLOBAL DRY BLOOD SPOT TEST BY GEOGRAPHY 2018-2026 ($MILLION)
TABLE 12 GLOBAL NEWBORN SCREENING MARKET BY TECHNOLOGY 2018-2026 ($ MILLION)
TABLE 13 GLOBAL HEARING SCREEN TECHNOLOGY MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 14 GLOBAL ELECTROPHORESIS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 15 GLOBAL TANDEM MASS SPECTROMETRY MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 16 GLOBAL PULSE OXIMETRY TECHNOLOGY MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 17 GLOBAL DNA BASED ASSAYS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 18 GLOBAL ENZYMES & IMMUNOASSAYS MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 19 GLOBAL NEWBORN SCREENING MARKET BY GEOGRAPHY 2018-2026 ($ MILLION)
TABLE 20 NORTH AMERICA NEWBORN SCREENING MARKET BY COUNTRY 2018-2026 ($ MILLION)
TABLE 21 EUROPE NEWBORN SCREENING MARKET BY COUNTRY 2018-2026 ($MILLION)
TABLE 22 ASIA-PACIFIC NEWBORN SCREENING MARKET BY COUNTRY 2018-2026 ($ MILLION)
TABLE 23 REST OF WORLD NEWBORN SCREENING MARKET BY REGION 2018-2026 ($ MILLION)

LIST OF FIGURES
FIGURE 1 GLOBAL NEWBORN SCREENING MARKET BY PRODUCT TYPE 2018-2026 ($ MILLION)
FIGURE 2 NORTH AMERICA NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 3 GLOBAL NEWBORN SCREENING INSTRUMENTS MARKET 2018-2026 ($ MILLION)
FIGURE 4 GLOBAL DRY BLOOD SPOT TEST SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 5 NEONATAL MORTALITY RATE (PER 1000 LIVE BIRTHS) 2006-2016
FIGURE 6 CAUSES OF DEATH AMONG NEWBORNS GLOBALLY (0-27 DAYS)
FIGURE 7 INFANT MORTALITY RATE IN 2016 IN DEVELOPING COUNTRIES (TOTAL DEATH/ 1000 LIVE BIRTHS)
FIGURE 8 FERTILITY RATE (AVERAGE BIRTHS PER WOMAN IN %) 2015
FIGURE 9 GLOBAL NEWBORN SCREENING INSTRUMENTS MARKET 2018-2026 ($ MILLION)
FIGURE 10 GLOBAL HEARING SCREENING INSTRUMENTS MARKET 2018-2026 ($ MILLION)
FIGURE 11 GLOBAL NEWBORN DISORDER SCREENING INSTRUMENTS MARKET 2018-2026 ($ MILLION)
FIGURE 12 GLOBAL PULSE OXIMETRY SCREENING INSTRUMENTS MARKET 2018-2026 ($ MILLION)
FIGURE 13 GLOBAL NEWBORN SCREENING REAGENTS & ASSAY KITS MARKET 2018-2026 ($ MILLION)
FIGURE 14 GLOBAL HEARING SCREENING TEST MARKET 2018-2026 ($ MILLION)
FIGURE 15 GLOBAL CRITICAL CONGENITAL HEART DISEASE (CCHD) TEST MARKET 2018-2026 ($ MILLION)
FIGURE 16 GLOBAL DRY BLOOD SPOT TEST MARKET 2018-2026 ($ MILLION)
FIGURE 17 GLOBAL HEARING SCREEN TECHNOLOGY MARKET 2018-2026 ($ MILLION)
FIGURE 18 GLOBAL ELECTROPHORESIS MARKET 2018-2026 ($ MILLION)
FIGURE 19 GLOBAL TANDEM MASS SPECTROMETRY MARKET 2018-2026 ($ MILLION)
FIGURE 20 GLOBAL PULSE OXIMETRY TECHNOLOGY MARKET 2018-2026 ($ MILLION)
FIGURE 21 GLOBAL DNA BASED ASSAYS MARKET 2018-2026 ($ MILLION)
FIGURE 22GLOBAL ENZYMES & IMMUNOASSAYS MARKET 2018-2026 ($ MILLION)
FIGURE 23 INVESTMENT PROPOSITION OF GLOBAL NEWBORN SCREENING MARKET BY GEOGRAPHY -2017
FIGURE 24 INVESTMENT PROPOSITION OF GLOBAL NEWBORN SCREENING MARKET BY TECHNOLOGY – 2017
FIGURE 25 UNITED STATES NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 26 CANADA NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 27 UNITED KINGDOM NEWBORN SCREENING MARKET 2018-2026 ($MILLION)
FIGURE 28 FRANCE NEWBORN SCREENING MARKET 2018-2026 ($MILLION)
FIGURE 29 GERMANY NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 30 NORDICS NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 31 RUSSIA NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 32 REST OF EUROPE NEWBORN SCREENING MARKET 2018-2026 ($MILLION)
FIGURE 33 CHINA NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 34 INDIA NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 35 JAPAN NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 36 AUSTRALIA NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 37 REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 38 LATIN AMERICA NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 39 MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET 2018-2026 ($ MILLION)
FIGURE 40 MARKET SHARE ANALYSIS OF GLOBAL NEWBORN SCREENING MARKET, 2017



【レポートのキーワード】

新生児スクリーニング

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 新生児スクリーニングの世界市場予測2018-2026(GLOBAL NEWBORN SCREENING MARKET FORECAST 2018-2026 )]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆